This website provides information about laboratory diagnostic services. The analyses presented are not a therapy and do not replace medical diagnosis and treatment. Medical decisions are made exclusively by your attending physician.
Fasting mimicking diet oncology investigates metabolic interventions as a potential approach to resensitize therapy-resistant tumors. Fasting mimicking diet cancer therapy, metabolic intervention cancer, differential stress resistance cancer cells, valter longo fasting cancer and nutrient deficiency tumor cell therapy together form the scientific basis for this innovative research approach, which is based on 30 years of juventology research.
The metabolic intervention tumor uses the phenomenon of differential stress resistance: healthy cells protect themselves under nutrient deficiency, while differential stress resistance tumor cells shows that cancer cells become more susceptible. Valter longo fasting therapy tumor approaches may enable the resensitization of resistant tumors.
nutrient deficiency cancer cell treatment exploits fundamental differences between healthy cells and tumor cells. This innovative interwencja metaboliczna rak research opens up new perspectives for oncology.
Fasting Mimicking Diet in oncology
A factual presentation of the scientific findings
When tumors become resistant: Can metabolic intervention resensitize?
The Fasting Mimicking Diet (FMD) is being investigated in current studies as a possible metabolic intervention approach during cancer therapies. The approach is based on 30 years of research by Prof. Valter Longo on longevity – the science of healthy aging.
Research into metabolic interventions in cancer investigates fundamental mechanisms that can influence the behavior of tumor cells. The focus is on the question of how healthy cells and cancer cells behave differently under nutrient deficiency – a phenomenon known as “differential stress resistance”.
Metabolic intervention cancer – basics of FMD research
Metabolic intervention cancer is based on the principle that tumor cells and healthy cells react differently to a lack of nutrients. Metabolic intervention tumor concepts make targeted therapeutic use of this biological difference. Research into metabolic intervention cancer shows promising results in overcoming resistance to therapy.
Differential stress resistance – Why cancer cells become more vulnerable
Differential stress resistance of cancer cells describes the core phenomenon of FMD research: when deprived of nutrients, healthy cells activate protective programs, whereas cancer cells cannot. Differential stress resistance makes tumor cells selectively vulnerable to attack. This differential stress resistance of cancer cells is the scientific key to the therapeutic potential of FMD.
Valter Longo Fasting Cancer – 30 years of juventology research
Valter longo fasting cancer research is revolutionizing our understanding of metabolism and tumor biology. Valter longo fasting therapy tumor approaches are being investigated in clinical trials for their effectiveness as a supplement to standard therapy. Valter longo fasting cancer findings open up new perspectives for integrative oncology.
Nutrient deficiency in tumour cells – resensitization of therapy-resistant tumours
Nutrient deficiency tumor cell therapy aims to overcome resistance mechanisms of cancer cells. In combination with chemotherapy or immunotherapy, nutrient deficiency tumor cell therapy can improve the effectiveness of existing treatments. Targeted nutrient-deficient tumor cell therapy is a promising approach in modern oncology.
The vision
Can metabolic intervention resensitize?
In the following video presentation from the 2nd iQMedix Medical Congress, you will learn how metabolic interventions are investigated in oncological therapy research and what scientific findings Prof. Valter Longo’s 30 years of research have produced. The lecture shows how the differential stress resistance between healthy cells and tumor cells is being investigated in experimental approaches and what initial clinical data is available from pilot studies for the combination with chemotherapy, hormone therapy and targeted therapies.
NOTE: The following video documents a specialist congress lecture. The contents represent the scientific discourse and are not a therapy recommendation. Therapeutic applications require official approval and medical supervision.
RESEARCH OBJECTIVES AND SCIENTIFIC QUESTIONS
Why metabolic interventions are increasingly being researched in oncology
Can short periods of fasting protect healthy cells?
Studies show that healthy cells switch to a protective mode when there is a lack of nutrients, while tumor cells have lost this mechanism due to their genetic changes. The video explains the molecular basis of this different reaction.
What role does IGF-1 play in tumor development?
Insulin-like growth factor 1 (IGF-1) is discussed as the central switch between nutrition and cell growth. Research findings by Prof. Longo show how low IGF-1 levels can influence tumor growth.
Is there clinical evidence for FMD in combination with standard therapies?
The video presents current study data investigating the combination of the Fasting Mimicking Diet with chemotherapy, hormone therapy and targeted therapies - with a particular focus on tolerability and quality of life.
Why do some tumors become resistant - and can fasting counteract this?
A central research question concerns therapy resistance: Can metabolic changes caused by FMD influence the response of resistant tumor cells to treatment? Experimental approaches to Prof. Longo's hypothesis will be presented.
How does FMD differ from conventional fasting?
The video explains the scientific concept behind the "fasting mimic" diet: a precisely composed, calorie-reduced diet that triggers the physiological effects of fasting without requiring complete abstinence from food. ahrungsverwicht zu erfordern.
Personalized approaches in cancer diagnostics
The research vision of iQMedix – to better understand and support cancer through innovative diagnostics and individualized concepts – is increasingly supported by scientific developments.
Your knowledge advantage starts here:
Vitamins are considered a natural part of a healthy diet. But in oncology, a more complex question arises: do they support the patient – or
Liquid Biopsy is a minimally invasive procedure for the analysis of circulating tumor cells (CTCs) in the blood. Instead of a surgical procedure, a blood
The focus is on the question of how healthy cells and cancer cells behave differently under nutrient deficiency – a phenomenon known as “differential stress
Ferroptosis provides a scientific background for the different responses to vitamin C therapies.
The latest developments make it clear that we are on the threshold of a new era in cancer diagnostics.
Scientific tumor lectures from the Therapeutic Congress May 2025. Expert lecture on tumor diagnostics & oncology.
Molecular precision cancer therapy is revolutionizing tumour medicine. Precision medicine & personalized therapy for better chances of recovery.
